Clinical Trial Update: Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lvosidenib (AK112) in combination with CapeOX chemotherapy and radiotherapy for unresectable metastatic MSS-type colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lvosidenib (AK112) (Lvosidenib)

Snippet

Sponsor: Fudan University | Conditions: CRC, MSS | Phase 2 | Status: NOT_YET_RECRUITING